{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:42:41Z","timestamp":1760982161563},"reference-count":23,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.vaccine.2007.06.021","type":"journal-article","created":{"date-parts":[[2007,6,30]],"date-time":"2007-06-30T11:13:01Z","timestamp":1183201981000},"page":"6321-6325","source":"Crossref","is-referenced-by-count":14,"title":["The 23-valent pneumococcal polysaccharide vaccine does not provide additional serotype antibody protection in children who have been primed with two doses of heptavalent pneumococcal conjugate vaccine"],"prefix":"10.1016","volume":"25","author":[{"given":"Paul","family":"Balmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter D.","family":"Arkwright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.06.021_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1473-3099(01)00170-0","article-title":"Estimates of world-wide distributions of child deaths from acute respiratory infections","volume":"2","author":"Williams","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2007.06.021_bib2","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0264-410X(99)00122-X","article-title":"The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known","volume":"17","author":"Fedson","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.021_bib3","unstructured":"www.hpa.org.uk\/infections\/topics_az\/pneumococcal\/."},{"key":"10.1016\/j.vaccine.2007.06.021_bib4","unstructured":"Immunisation against infectious disease \u201cThe Green Book\u201d. In: Salsbury D, Ramsay M, Noakes K, editors. Department of Health, U.K. TSO 2006 Third Edition. www.dh.gov.uk\/PolicyAndGuidance\/HealthAndSocialCareTopics\/GreenBook\/GreenBookGeneralInformation\/GreenBookGeneralArticle\/fs\/en?CONTENT_ID=4097254&chk=isTfGX."},{"key":"10.1016\/j.vaccine.2007.06.021_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety, and immunogenicity of heptavalent pneumococcal conjugate vaccine in children","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2007.06.021_bib6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/00006454-200209000-00005","article-title":"Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia","volume":"21","author":"Black","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2007.06.021_bib7","first-page":"S2","article-title":"Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults","volume":"24","author":"Black","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.021_bib8","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1001\/jama.270.15.1826","article-title":"Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations","volume":"270","author":"Butler","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2007.06.021_bib9","article-title":"Vaccines for preventing pneumococcal infection in adults","volume":"4","author":"Dear","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2007.06.021_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1473-3099(03)00514-0","article-title":"Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence","volume":"3","author":"Mangtani","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2007.06.021_bib11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1023\/B:EJEP.0000024701.94769.98","article-title":"The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses","volume":"19","author":"Melegaro","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.vaccine.2007.06.021_bib12","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1016\/j.vaccine.2006.03.088","article-title":"Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity","volume":"24","author":"Uddin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.021_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jim.2004.11.006","article-title":"Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes","volume":"296","author":"Lal","year":"2005","journal-title":"J Immunol Meth"},{"key":"10.1016\/j.vaccine.2007.06.021_bib14","first-page":"289","article-title":"Assessment of functional antibody responses","volume":"87","author":"Borrow","year":"2003","journal-title":"Meth Mol Med"},{"key":"10.1016\/j.vaccine.2007.06.021_bib15","unstructured":"World Health Organisation. Pneumococcal conjugate vaccines. Recommendations for the production and control of pneumococcal conjugate vaccines. WHO Tech. Rep. Ser. 2005;927:64\u201398."},{"key":"10.1016\/j.vaccine.2007.06.021_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2007.01.119","article-title":"Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies","author":"Siber","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.021_bib17","first-page":"127","article-title":"IgG2 subclass restriction of antibody to pneumococcal polysaccharides","volume":"63","author":"Barrett","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2007.06.021_bib18","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/CDLI.11.6.1100-1104.2004","article-title":"Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults","volume":"11","author":"Southern","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.06.021_bib19","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1086\/428135","article-title":"Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine","volume":"191","author":"Musher","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.06.021_bib20","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.vaccine.2003.11.038","article-title":"Pneumococcal vaccines: an update on current strategies","volume":"22","author":"Bogaert","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.021_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10408410600822942","article-title":"Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies","volume":"32","author":"Tai","year":"2006","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.vaccine.2007.06.021_bib22","unstructured":"Scott DA, Komjathy SF, Ruckle J, Supan L, dar M, Baker S, et al. Safety and immunogenicity of the 13-valent pneumococcal conjugate vaccine in healthy adults. Proceedings of the fifth international symposium on pneumococci and pneumococcal diseases, Alice Springs, Central Australia, 2\u20136 April 2006, 255 pp."},{"key":"10.1016\/j.vaccine.2007.06.021_bib23","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.vaccine.2006.12.008","article-title":"ELISA IgG concentrations and opsonophagocytic activity following pneumococcal protein D conjugate vaccination and relationship to efficacy against acute otitis media","volume":"25","author":"Schuerman","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07006986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07006986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T21:45:38Z","timestamp":1587678338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07006986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":23,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0264410X07006986"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.06.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}